Skip to content
EU Startups News
  • Funding
  • Launch
  • Partnership
  • Acquisition
  • Policy
  • Exit & IPO

ALP Bio

Swiss Biotech Startup ALP Bio Secures €161,000 From Venture Kick for Drug Safety Platform

July 3, 2026 by Sophie Renard

Swiss biotech startup ALP Bio has secured €161,000 from Venture Kick to develop a platform combining human immune tissue models and AI to predict immune-related risks in biologic drug development, improving safety and success rates.

Categories Funding Tags ALP Bio, Healthtech, Pre-seed, Switzerland, Under €1M Leave a comment
Browse by Country

Latest

Norwegian-Swedish Startup Vidda Launches AI Platform to Streamline Compliance in Regulated IndustriesNov 16, 2026
Blackbird Coffee Lands €16 Million Series A to Expand Workplace Coffee Platform Across EuropeNov 16, 2026
Romanian Fintech BT Broker Launches Free AI-Powered CASCO Vehicle Inspection ToolNov 16, 2026
Swedish workforce management platform Quinyx cuts 14% of staff in restructuring pushNov 16, 2026
ElevenLabs Reaches €19 Billion Valuation After Secondary Share Sale, Three Years After European Pre-Seed BackingNov 16, 2026

EU Markets

European Startups Navigate a Week of Big Money Moves, Regulatory Shifts, and Market TurbulenceNov 13, 2026
Europe's Financial Pulse: AI Bets, Rate Signals, and What Founders Need to Know This WeekNov 6, 2026
European Markets Flash Caution Signals: What This Week's Financial Turbulence Means for Startup FoundersOct 30, 2026
European Startups, Brace Yourselves: Rate Pressures, AI Disruption, and a €550M Legal Tech Unicorn Define This Week's Financial LandscapeOct 23, 2026

EU Startups News
• About Us • Privacy Policy

Follow Us

LinkedIn X / Twitter Facebook

Stay informed

Get the latest European startup news delivered to your inbox every week. For broader markets news, visit: EU Finance News

No spam. Unsubscribe anytime.

By continuing to use this site you agree to our Privacy Policy and the use of cookies.

© 2026 EU Startups News • Built with GeneratePress

By continuing to use this site you agree to our Privacy Policy and the use of cookies.